Overexpression of TOP2A is associated not only with tumorigenesis and cancer progression in various types of cancer, such as breast, hepatocellular, colorectal, lung, and ovarian, but also with increased proliferation, angiogenesis, metastasis, and drug resistance [61,62,63]. Here, TOP2A is linked to cancer.